Skin Research Institute of Singapore (SRIS)
NLRP1: How the body senses the common cold virus
28 Jun 2021The mysterious trigger of the NLRP1 inflammasome sensor has finally been identified: a protease found in the common cold-causing human rhinovirus tells our body that it has been invaded.
A recipe for mini livers
23 Apr 2021For the first time, researchers have generated lab-grown livers that have functioning bile canaliculi, an important step towards modeling complex liver diseases.
PORE-ing over RNA structures
19 Apr 2021A new sequencing technique called PORE-cupine combines artificial intelligence to reveal ribonucleic acid structures in cells.
Dusting away dandruff
5 Apr 2021Zinc pyrithione shampoos tower above other antifungals for keeping dandruff at bay, an A*STAR study finds.
Providing closure in anencephaly research
19 Mar 2021A genetic cause for anencephaly, a common neural tube defect found in developing fetuses, has been identified for the first time.
Scratching the surface of atopic dermatitis
3 Mar 2021Differences in the skin microbiome could reveal clues as to why some cases of atopic dermatitis are more severe than others.
Repurposing a cancer drug for eczema
27 Nov 2020A microRNA called miR-355 has been identified as the key regulator of skin cell differentiation in patients with atopic dermatitis.
Tiny but full of energy
28 Oct 2020Researchers at A*STAR have discovered how a class of small proteins is essential for metabolism.
Delivering drugs in a pinch
21 Oct 2020Using magnets, scientists have developed an innovative pressure-based technique that represents a new frontier in needle-free drug delivery.
Aid for chronic wounds
11 Aug 2020A new generation of smart dressings could help to guard against the danger of wounds that do not heal.
Marking out gastric (cancer) stem cells
10 Jun 2020A*STAR scientists have uncovered a novel surface marker that identifies stem cells and potential cancer stem cells in the distal stomach.
Targeting triple-negative breast cancer
10 Mar 2020A*STAR scientists have identified a microRNA that can potentially be targeted for the treatment of triple-negative breast cancer.